Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post Marketing Surveillance on Long Drug Use of Micombi Combination Tablets in Patients With Hypertension

NCT01050062 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.

NCT NCT01050062
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01050062 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post Marketing Surveillance on Long Drug Use of Micombi Combination Tablets in Patients With Hypertension
Lead sponsor
Boehringer Ingelheim
Phase
Observational
Overall status
Completed
Start date
January 31, 2010
Completion date
December 31, 2011
Enrollment
1,452 (actual)
Sites
314

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension